Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Penumbra, Inc.
As the pandemic unfolds with an uncertain outcome, US securities analysts that cover publicly traded medtech companies are developing mathematical models to estimate the impact of the COVID-19 pandemic on medtech companies.
R&D Roundup, November 2019: LimFlow Starts Pivotal Trial Of Peripheral Shunt; Conservative Coronary Treatment Matches Intervention In Trial
An overview of November’s 10 most-read Medtech Insight articles on topics related to research and development of new medical technology.
Results of the EXTRACT PE trial, presented at the Vascular Interventional Advances Annual Meeting in Las Vegas, will support an application to the US FDA for Penumbra’s Indigo system for aspiration mechanical thrombectomy in patients with acute pulmonary embolism.
Stryker's Trevo Retriever is the first stent retriever approved by US FDA as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset, matching the time window recommended in the latest professional treatment guidelines. Now, the company is trying to help the stroke-care system in the US catch up to the science.
- Surgical Equipment & Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- Crossmed S.p.a
- MVI Health